91 assets in Chronic Pain Syndrome

Therapeutic assets addressing Chronic Pain Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
(±)-Tramadol Chronic Pain Syndrome	EMS	P4	BBB (78)
Lidocaine Chronic Pain Syndrome	National and Kapodistrian University of Athens	P4	BBB (75)
Methadone Chronic Pain Syndrome	Cari Health Inc.	P4	BBB (75)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Chronic Pain Syndrome	Stanford University	P4	BBB (74)
Fentanyl Chronic Pain Syndrome	Aga Khan University	P4	BBB (74)
Nepenthe Chronic Pain Syndrome	Bursa City Hospital	P4	BBB (74)
Buprenorphine Chronic Pain Syndrome	Medical University of South Carolina	P4	BBB (73)
Jnj-54135419 Chronic Pain Syndrome	Beijing Tiantan Hospital	P4	BBB (73)
Oxycodone Chronic Pain Syndrome	Mayo Clinic	P4	BBB (73)
Pregabalin Chronic Pain Syndrome	Federico II University	P4	BBB (73)
Ibuprofen Chronic Pain Syndrome	Aga Khan University	P4	BBB (72)
Marcaine Chronic Pain Syndrome	Hadassah Medical Organization	P4	BBB (72)
Naltrexone Chronic Pain Syndrome	Hospital for Special Surgery, New York	P4	BB (71)
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE Chronic Pain Syndrome	Second Affiliated Hospital, School of Medicine, Zhejiang University	P4	BB (70)
Naproxen Chronic Pain Syndrome	Endeavor Health	P4	BB (69)
Oxytocin Chronic Pain Syndrome	Wake Forest University Health Sciences	P4	BB (69)
Ramifentanyl Chronic Pain Syndrome	Beijing Tiantan Hospital	P4	BB (69)
Tizanidine Chronic Pain Syndrome	Stanford University	P4	BB (69)
Duloxetine Chronic Pain Syndrome	Parc de Salut Mar	P4	BB (68)
Gabapentin Chronic Pain Syndrome	Federico II University	P4	BB (68)
Sufentanyl Chronic Pain Syndrome	Tianjin Medical University General Hospital	P4	BB (68)
Dexmedetomidine Chronic Pain Syndrome	Cairo University	P4	BB (67)
Dexasone Chronic Pain Syndrome	Peking University Third Hospital	P4	BB (66)
Diclofenac Chronic Pain Syndrome	The Cleveland Clinic	P4	BB (66)
Hyaluronate Chronic Pain Syndrome	Sverdlovsk Regional Clinical Hospital No.1	P4	BB (66)
Palmitic Monoethanolamide Chronic Pain Syndrome	Navy Medical Center San Diego	P4	BB (66)
Acetylcysteine Chronic Pain Syndrome	Vanderbilt University Medical Center	P4	BB (65)
Dextrose Solution Chronic Pain Syndrome	Kastamonu University	P4	BB (65)
Tapentadol Chronic Pain Syndrome	University of Thessaly	P4	BB (65)
Triamcinolone Hexacetonide Chronic Pain Syndrome	Kastamonu University	P4	BB (65)
Jincaopian Tablets Chronic Pain Syndrome	Beijing Konruns Pharmaceutical Co., Ltd.	P3	BB (64)
Ropivacaine Chronic Pain Syndrome	Biobizkaia Health Research Institute	P4	BB (64)
Sevoflurane Chronic Pain Syndrome	Nantes University Hospital	P4	BB (64)
Amitriptyline Chronic Pain Syndrome	Federico II University	P4	B (63)
Autologous Conditioned Plasma Chronic Pain Syndrome	Biobizkaia Health Research Institute	P4	B (63)
Flosteron Chronic Pain Syndrome	Biobizkaia Health Research Institute	P4	B (63)
Midazolam Chronic Pain Syndrome	National Taiwan University Hospital	P3	B (63)
Ondansetron Chronic Pain Syndrome	Tianjin Medical University General Hospital	P4	B (62)
Vitamin D Chronic Pain Syndrome	Taipei Medical University Hospital	P4	B (62)
L-Bupivacaine Chronic Pain Syndrome	Tanta University	P4	B (61)
Carbocaine Chronic Pain Syndrome	Nantes University Hospital	P3	B (60)
Ketamine Intravenous Infusion Chronic Pain Syndrome	NYU Langone Health	P3	B (60)
Oliceridine Chronic Pain Syndrome	Tianjin Medical University General Hospital	P4	B (60)
Suxamethonium Chronic Pain Syndrome	Nantes University Hospital	P3	B (60)
Xeomin® Chronic Pain Syndrome	Nantes University Hospital	P3	B (60)
Eukystol Chronic Pain Syndrome	Western Michigan University School of Medicine	P4	B (59)
LEAN Chronic Pain Syndrome	Centre Hospitalier Universitaire de Nīmes	P4	B (59)
Teonanacatl Chronic Pain Syndrome	Yale University	P2	B (59)
Cyclobenzaprine Chronic Pain Syndrome	Christiana Care Health Services	P4	B (58)
Ketorolac Chronic Pain Syndrome	Western Michigan University School of Medicine	P4	B (58)

Showing 1 to 50 of 91 assets

PreviousPage 1 of 2Next